Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pfizer Stock: A Top Bet for 2021?

TheMotleyFool

0 0

If you've spent any amount of time hunting for stocks to buy in 2021, Pfizer (NYSE: PFE) and its recently authorized coronavirus vaccine probably caught your attention.

Pfizer and its partner BioNTech (NASDAQ: BNTX) rapidly developed a new vaccine to prevent COVID-19. This is an enormous achievement expected to generate more than $10 billion in top-line sales for the collaboration partners this year, and then sharply taper off in 2022. That's nothing to sneeze at, but it's important to realize Pfizer already expects more than $40 billion in total revenue this year.

Image source: Getty Images.

Source Fool.com

Like: 0

PFE

Share